schemaVersion:

Form C: Filer Information

Filer CIK:
0001787792 
Filer CCC:
XXXXXXXX 
Period:

12-31-2025 

Is this a LIVE or TEST Filing?Radio button checked LIVE Radio button not checked TEST
Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption?Checkbox not checked
Would you like a Return Copy?Checkbox not checked

Submission Contact Information

Name:
 
Phone Number:
 
Contact E-Mail Address:
 
Notify via Filing Website only?Checkbox not checked

Form C: Issuer Information

Issuer Information

Name of Issuer:

Fisher Wallace Laboratories, Inc. 

Legal Status of Issuer:

Form:

Corporation 

Jurisdiction of Incorporation/Organization:

DELAWARE  

Date of Incorporation/Organization:

08-23-2019 

Physical Address of Issuer:

Address 1:

630 FLUSHING AVENUE, BOX 104 

City:

BROOKLYN 

State/Country:

NEW YORK  

Mailing Zip/Postal Code:

11206 

Website of Issuer:

fisherwallace.com 

Is there a Co-issuer? Radio button not checked Yes Radio button checked No

Form C: Annual Report Disclosure Requirements

Annual Report Disclosure Requirements

Current Number of Employees:

3.00 

Total Assets Most Recent Fiscal Year-end:

144634.00 

Total Assets Prior Fiscal Year-end:

154382.00 

Cash and Cash Equivalents Most Recent Fiscal Year-end:

48142.00 

Cash and Cash Equivalents Prior Fiscal Year-end:

41626.00 

Accounts Receivable Most Recent Fiscal Year-end:

0.00 

Accounts Receivable Prior Fiscal Year-end:

0.00 

Short-term Debt Most Recent Fiscal Year-end:

591311.00 

Short-term Debt Prior Fiscal Year-end:

596721.00 

Long-term Debt Most Recent Fiscal Year-end:

693612.00 

Long-term Debt Prior Fiscal Year-end:

925582.00 

Revenue/Sales Most Recent Fiscal Year-end:

34261.00 

Revenue/Sales Prior Fiscal Year-end:

47412.00 

Cost of Goods Sold Most Recent Fiscal Year-end:

5049.00 

Cost of Goods Sold Prior Fiscal Year-end:

3012.00 

Taxes Paid Most Recent Fiscal Year-end:

0.00 

Taxes Paid Prior Fiscal Year-end:

0.00 

Net Income Most Recent Fiscal Year-end:

-1447538.00 

Net Income Prior Fiscal Year-end:

-1579900.00 

Form C: Signature

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

Issuer:

Fisher Wallace Laboratories, Inc. 

Signature:

/Kelly Roman/ 

Title:

Chief Executive Officer and Director 

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:

/Kelly Roman/ 

Title:

Chief Executive Officer and Director 

Date:

04-30-2026